In vivo, the protective effect of BMSCs on CML cells is mainly due to the secretion of CXCL12 by BMSCs, which activate CXCR4 by its interaction with CXCR4, thus promoting the survival rate of CML cells (35). Here, CXCL12 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.